Mortality risk stratification by combining BRAF V600E and TERT promoter mutations in papillary thyroid cancer: genetic duet of BRAF and TERT promoter mutations in …
Importance BRAF V600E andTERTpromoter mutations can coexist in papillary thyroid
cancer (PTC). This genetic duet was indicated to be involved in the aggressiveness of PTC …
cancer (PTC). This genetic duet was indicated to be involved in the aggressiveness of PTC …
Mortality Risk Stratification by Combining BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Cancer: Genetic Duet of BRAF and TERT Promoter …
R Liu, J Bishop, G Zhu, T Zhang, PW Ladenson… - JAMA …, 2017 - europepmc.org
Results Papillary thyroid cancer-specific mortality occurred in 4 of 629 patients (0.6%) with
neither mutation; 7 of 292 (2.4%) with BRAF V600E alone; 4 of 64 (6.3%) with TERT …
neither mutation; 7 of 292 (2.4%) with BRAF V600E alone; 4 of 64 (6.3%) with TERT …
Mortality risk stratification by combining BRAF V600E and TERT promoter mutations in papillary thyroid cancer genetic duet of BRAF and TERT promoter mutations in …
R Liu, J Bishop, G Zhu, T Zhang… - JAMA …, 2017 - utsouthwestern.elsevierpure.com
Abstract IMPORTANCE BRAF V600E and TERT promoter mutations can coexist in papillary
thyroid cancer (PTC). This genetic duet was indicated to be involved in the aggressiveness …
thyroid cancer (PTC). This genetic duet was indicated to be involved in the aggressiveness …
[引用][C] Mortality Risk Stratification by Combining BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Cancer
R Liu, J Bishop, G Zhu, T Zhang, PW Ladenson… - JAMA Oncology, 2017 - cir.nii.ac.jp
Mortality Risk Stratification by Combining <i>BRAF </i>V600E and <i>TERT</i> Promoter
Mutations in Papillary Thyroid Cancer | CiNii Research CiNii 国立情報学研究所 学術情報 …
Mutations in Papillary Thyroid Cancer | CiNii Research CiNii 国立情報学研究所 学術情報 …
[PDF][PDF] Mortality Risk Stratification by Combining BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Cancer Genetic Duet of BRAF and TERT Promoter …
R Liu, J Bishop, G Zhu, T Zhang, PW Ladenson, M Xing - 2016 - researchgate.net
DESIGN, SETTING, AND PARTICIPANTS This genetic-clinical correlation study examined
BRAF V600E and TERT promoter mutations (chr5: 1,295,228 C> T and chr5: 1,295,250 C> …
BRAF V600E and TERT promoter mutations (chr5: 1,295,228 C> T and chr5: 1,295,250 C> …
Mortality risk stratification by combining BRAF V600E and TERT promoter mutations in papillary thyroid cancer genetic duet of BRAF and TERT promoter mutations in …
R Liu, J Bishop, G Zhu, T Zhang… - JAMA …, 2017 - pure.johnshopkins.edu
Abstract IMPORTANCE BRAF V600E and TERT promoter mutations can coexist in papillary
thyroid cancer (PTC). This genetic duet was indicated to be involved in the aggressiveness …
thyroid cancer (PTC). This genetic duet was indicated to be involved in the aggressiveness …
Mortality Risk Stratification by Combining BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Cancer: Genetic Duet of BRAF and TERT Promoter …
R Liu, J Bishop, G Zhu, T Zhang… - JAMA …, 2017 - pubmed.ncbi.nlm.nih.gov
Importance BRAF V600E and TERT promoter mutations can coexist in papillary thyroid
cancer (PTC). This genetic duet was indicated to be involved in the aggressiveness of PTC …
cancer (PTC). This genetic duet was indicated to be involved in the aggressiveness of PTC …
Mortality Risk Stratification by Combining BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Cancer Genetic Duet of BRAF and TERT Promoter …
R Liu, J Bishop, G Zhu, T Zhang, PW Ladenson, M Xing - JAMA, 2017 - jamanetwork.com
DESIGN, SETTING, AND PARTICIPANTS This genetic-clinical correlation study examined
BRAF V600E and TERT promoter mutations (chr5: 1,295,228 C> T and chr5: 1,295,250 C> …
BRAF V600E and TERT promoter mutations (chr5: 1,295,228 C> T and chr5: 1,295,250 C> …